Theileria annulata sporozoite antigen fused to hepatitis B core antigen used in a vaccination trial
- 1 January 1995
- Vol. 13 (13) , 1152-1160
- https://doi.org/10.1016/0264-410x(95)00026-w
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Theileria annulata sporozoite surface antigen (SPAG‐1) contains neutralizing determinants in the C terminusParasite Immunology, 1994
- Adjuvants: current status, clinical perspectives and future prospectsImmunology Today, 1993
- Extensive polymorphism of the BOLA‐DRB3 gene distinguished by PCR‐RFLPAnimal Genetics, 1992
- Mimicry of elastin repetitive motifs by Theileria annulata sporozoite surface antigenMolecular and Biochemical Parasitology, 1992
- Foreign epitopes in immunodominant regions of hepatitis B core particles are highly immunogenic and conformationally restrictedVaccine, 1991
- Presentation and Immunogenicity of Viral Epitopes on the Surface of Hybrid Hepatitis B Virus Core Particles Produced in BacteriaJournal of General Virology, 1990
- Recombinant core particles of hepatitis B virus exposing foreign antigenic determinants on their surfaceFEBS Letters, 1989
- In vivo depletion of BoT4 (CD4) and of non‐T4/T8 lymphocyte subsets in cattle with monoclonal antibodiesEuropean Journal of Immunology, 1989
- Theileria parva in cattle: Characterization of infected lymphocytes and the immune responses they ProvokeVeterinary Immunology and Immunopathology, 1989
- Improved immunogenicity of a peptide epitope after fusion to hepatitis B core proteinNature, 1987